Clinical TrialsSearch results
Number of results: 854
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Recruiting
- A Platform Trial of Optimal Treatment for Pneumonia including (Re-)Emerging Infections
- Community-acquired pneumonia and COVID-19 infection
- Fujitani Shigeki
- 2021-06-14
Recruiting
- A Prospective Cohort Multi-Institutional Observational Study of the Gut Microbiota in Gastroenterological Cancer
- Gastrointestinal cancer
- Endo Itaru
- 2022-08-02
Recruiting
- A Randomised phase III clinical trial of combined therapy with CPT-11/CDDP versus CPT-11 alone in patients with advaneced or recurrent gastric cancer resistant to S-1
- Gastric Cancer
- ECRIN
- 2009-10-01
Recruiting
- A randomized controlled trial of the effect of electrical muscle stimulation (EMS) therapy on improving walking function in elderly people who can walk independently
- Flaility, Extnding healthy life
- Nishii Mototsugu
- 2024-09-02
Recruiting
- A randomized controlled trial of treatments for ISSNHL and ALHL
- idiopathetic sudden sensorineuronal hearing loss and acute low-tone sensorineural hearing loss
- Hyakusoku Hiroshi
- 2022-03-26
Recruiting
- A Randomized Prospective Study on Age-related Changes in Peri-Stem Femoral Bone Mineral Density and Bone Morphology of Curved-Short Stems and Fully Hydroxyapatite-Coated Stems in Total Hip Arthroplasty
- osteoarthritis of the hip
- Hirakawa Kazuo
- 2023-11-19
Recruiting
- A Rollover Study for Participants Previously Enrolled in a Genentech and/or F. Hoffman-La Roche Sponsored Study (UmbrellaMAX)
- Cancer
- Timothy Eisen
- 2023-08-04
Recruiting
- A single-arm trial of daprodustat for low-risk myelodysplastic syndromes
- Myelodysplastic syndromes
- Kunimoto Hiroyoshi
- 2024-05-13
Recruiting
- A single-center, prospective, observational study investigating the levels of insulin antagonist hormones on diabetic ketosis and hyperglycemic emergencies on admission
- diabetes mellitus
- Suzuki Agena
- 2020-12-24
Recruiting
- A Study About How Well TAK-279 Works and Its Safety in Participants With Moderate-to-severe Plaque Psoriasis During 52 Weeks of Treatment
- Plaque Psoriasis
- Shikamura Mitsuhiro
- 2024-01-22